Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework

OBJECTIVES: To explore reasons for the lack of uptake of ‘Better Care Better Value (BCBV)’ prescribing indicators for renin–angiotensin–aldosterone system (RAAS) inhibitors and identify learning lessons to inform the implementation of future prescribing policies. DESIGN: In-depth, semistructured int...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurdi, Amanj, Elliott, Rachel Ann, Chen, Li-Chia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312337/
https://www.ncbi.nlm.nih.gov/pubmed/32580986
http://dx.doi.org/10.1136/bmjopen-2019-035910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312337/
https://www.ncbi.nlm.nih.gov/pubmed/32580986
http://dx.doi.org/10.1136/bmjopen-2019-035910

Ejemplares similares